Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Alexion co-founder raises $40M for Gennao Bio

A gene therapy biotech helmed by an Alexion Pharmaceuticals co-founder has raised $40 million to develop a pipeline of drugs based on technology it licensed...

| By Kelley Gipson

Couture joins CytoVeris as Director of Quality

CytoVeris reports that Henry Couture has joined the company as Director of Quality. Mr. Couture has an extensive background with over 20 years of experience leading...

| By Kelley Gipson

Osmol initiates IND studies re neuropathy

Osmol Therapeutics reports it has initiated Investigational New Drug (IND) enabling studies to develop a therapy to prevent chemotherapy-induced peripheral neuropathy (CIPN). A phase 1...

| By Kelley Gipson

Yale and BI seek applications from postdocs

Yale University and Boehringer Ingelheimare seeking applications for Postdoctoral Researchers for a newly launched Biomedical Data Science Fellowship, which is a three-year full-time program. Applicants...

| By Kelley Gipson

Cybrexa doses first patient in Phase 1/2 trial

Cybrexa Therapeutics reports that the first patient has been dosed in a Phase 1/2 clinical trial evaluating CBX-12 (alphalex™-exatecan), the company’s lead therapeutic candidate. The...

| By Kelley Gipson

InveniAI® appoints Dr. Salvatore Alesci as CSO

InveniAI® reports the appointment of Salvatore (Salvo) Alesci, M.D., Ph.D., as its Chief Scientific Officer. Dr. Alesci, a physician-scientist, R&D strategist, and science policy influencer...

| By Kelley Gipson

SCSU scholarships to support science teachers

Southern Connecticut State University has received a grant from the National Science Foundation to increase the number of physics, chemistry, and math teachers in high-needs school...

| By Kelley Gipson

Taconic launches new COVID-19 mouse model

Taconic Biosciences has launched a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit. In October 2020, Taconic launched its...

| By Kelley Gipson

New Haven company marketing COVID test on Amazon

New Haven’s Precipio has begun marketing a new 20-minute COVID-19 antibody test on e-commerce giant Amazon’s business platform. The Science Park-based diagnostics company has a...